← Leaderboards
Pui Ying Lam
Medical College Of Wisconsin
$2,067,716
Attributed
$2,291,426
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $586.9K · FY2019–25$1M$750K$500K$250K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,291,426 · 5
By mechanism
R21$876,420 · 2
R00$839,184 · 1
R35$390,000 · 1
K99$185,822 · 1
Top collaborators
- Steve Mangos2 shared
Most similar at Medical College Of Wisconsin
Same institution · by research overlap
- Cheryl Louise Stucky$17,363,315
- Cheryl A Hillery$7,803,742
- Matthew B Veldman$1,564,295
Others in their field
Other Emerging Leaders on “Animals”
- Kevin Urdahl · Seattle Children'S Hospital$84,741,409
- Ted Ross · University Of Georgia$70,992,558
- Leonard Freedman · Leidos Biomedical Research, Inc.$63,986,959
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Sarah Fortune · Harvard School Of Public Health$51,119,645
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$49,241,299
Research focus
AnimalsBiologyOpticsImageCellsIn VivoComplexResponseOrganZebrafishTissuesSmall MoleculeProteinsScreeningPhysiologicalResearch PersonnelMolecularOptogeneticsTrainingBrainBiological ProcessLightFoundationsEmbryo
Grant awards (12)
Ontogeny and kinetics of innate immune cells in health and disease$390,000
R35 · FY2025 · GM · contact PI
Developing Danionella cerebrum as an adult vertebrate model to study kidney disease$196,859
R21 · FY2025 · DK
Developing Danionella cerebrum as an adult vertebrate model to study kidney disease$250,561
R21 · FY2024 · DK
Danionella cerebrum as a transparent vertebrate adult model for studying immune-related biological processes and diseases$195,000
R21 · FY2024 · OD · contact PI
Developing novel chemo-optogenetic tools for in vivo applications$249,001
R00 · FY2023 · NS · contact PI
Danionella cerebrum as a transparent vertebrate adult model for studying immune-related biological processes and diseases$234,000
R21 · FY2023 · OD · contact PI
Developing Novel Chemo-optogenetic Tools for in Vivo Applications$65,071
R00 · FY2023 · NS · contact PI
Developing novel chemo-optogenetic tools for in vivo applications$27,110
R00 · FY2023 · NS · contact PI
Developing novel chemo-optogenetic tools for in vivo applications$249,001
R00 · FY2022 · NS · contact PI
Developing novel chemo-optogenetic tools for in vivo applications$249,001
R00 · FY2021 · NS · contact PI
Developing novel chemo-optogenetic tools for in vivo applications$92,911
K99 · FY2020 · NS · contact PI
Developing novel chemo-optogenetic tools for in vivo applications$92,911
K99 · FY2019 · NS · contact PI